Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLGW) Other Non Operating Income (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Other Non Operating Income for 2 consecutive years, with -$2.8 million as the latest value for Q3 2017.

  • Quarterly Other Non Operating Income changed 0.0% to -$2.8 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was -$8.5 million through Sep 2017, changed N/A year-over-year, with the annual reading at -$408294.0 for FY2018, N/A changed from the prior year.
  • Other Non Operating Income for Q3 2017 was -$2.8 million at Bone Biologics, roughly flat from -$2.8 million in the prior quarter.
  • The five-year high for Other Non Operating Income was -$4862.0 in Q1 2016, with the low at -$2.8 million in Q2 2016.